Back to discover
Drug

Daidzein

In clinical development
Emerging researchEarly-to-mid development
Also known as 4',7-dihydroxyisoflavone, 7-Hydroxy-3-(4-hydroxyphenyl)-4-benzopyrone, 7-hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one, Isoaurostatin+2 more

4',7-dihydroxyisoflavone, 7-Hydroxy-3-(4-hydroxyphenyl)-4-benzopyrone, 7-hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one, Isoaurostatin, Daidzeol, 7,4'-dihydroxyisoflavone.

RxNorm22255ChEMBLCHEMBL8145UNII6287WC5J2L
2
Research papers
1
Active clinical trials
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Daidzein
Aliases & brands
4',7-dihydroxyisoflavone7-Hydroxy-3-(4-hydroxyphenyl)-4-benzopyrone7-hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-oneIsoaurostatinDaidzeol7,4'-dihydroxyisoflavone
RxNorm CUI
22255
ChEMBL ID
CHEMBL8145
UNII
6287WC5J2L

Clinical trials

1 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
1
registered trials across all phases
1
Active studies
1
Recruiting
PHASE DISTRIBUTIONn = 1
Phase 21

Research activity

2 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
20192025
Major research themes6
Diet1Gastrointestinal Microbiome1Genistein1Hormone Replacement Therapy1Isoflavones1Phytoestrogens1
Journals, researchers & institutions
Top journals
  • International journal of molecular sciences1
  • Nutrients1
Leading researchers
  • Arunotayanun W1
  • Chaichit S1
  • Chaikhong K1
  • Chupradit S1
  • Flórez AB1
  • Intharuksa A1
  • Koonrungsesomboon N1
  • Mayo B1
Leading institutions
free-text, unnormalised
  • Center for Medical and Health Technology Assessment (CM-HTA)1
  • Center of Excellence on Natural Products for Neuroprotection and Anti-Ageing1
  • Chiang Mai University1
  • Clinical Research Center for Food and Herbal Product Trials and Development (CR-FAH)1
  • College of Public Health Sciences1
  • Graduate School1

Related drugs

2 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Equol

Frequently co-studied with Daidzein in the research literature.

1 shared paper
Genistein

Frequently co-studied with Daidzein in the research literature.

1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials